Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Urinary Tract Obstruction Treatment Devices Market?
The market for urinary tract obstruction treatment devices has experienced substantial growth in recent years. It is anticipated to expand from $1.4 billion in 2025 to $1.48 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.1%. This historical expansion can be attributed to several factors, including a rise in kidney stone prevalence, aging population growth, BPH incidence increase, hospital urology expansion, and catheterization procedure growth.
The urinary tract obstruction treatment devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $1.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This expansion during the projection period stems from factors such as the increased integration of laser-based urology, the rise of outpatient obstruction treatments, innovations in advanced stent biomaterials, the utilization of robotic-assisted urology procedures, and initiatives aimed at shortening hospital stays. Key trends anticipated for this period encompass minimally invasive obstruction management, sophisticated laser lithotripsy systems, enhanced ureteral stent designs, various endoscopic stone removal techniques, and solutions promoting quicker post-procedure recovery.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20989&type=smp
Which Drivers Are Supporting The Rise Of The Urinary Tract Obstruction Treatment Devices Market?
The rising incidence of kidney disease is anticipated to drive the expansion of the urinary tract obstruction treatment devices market. Kidney disease is characterized by renal dysfunction or damage, hindering the kidneys’ ability to filter waste and excess fluids from the bloodstream. Several factors contribute to the escalating prevalence of kidney disease, including an aging demographic, increased rates of diabetes and hypertension, and detrimental lifestyle choices. Medical intervention is necessary for kidney disease to alleviate kidney pressure and maintain renal function. When the condition progresses, urinary tract obstructions become more frequent, thereby heightening the demand for devices that manage these obstructions and avert further kidney damage. For example, a report published in June 2023 by Kidney Research UK, a non-profit organization based in the UK, indicated that roughly 7.2 million individuals in the UK are currently afflicted with chronic kidney disease, which constitutes over 10% of the populace. Among these, 3.25 million are experiencing advanced stages of the illness, with another 3.9 million in its initial phases. Projections indicate that by 2033, the population affected by chronic kidney disease will climb to 7.61 million. Consequently, the growing prevalence of kidney disease is expected to fuel the growth of the urinary tract obstruction treatment devices market.
What Leading Segments Are Studied In The Urinary Tract Obstruction Treatment Devices Market?
The urinary tract obstruction treatment devices market covered in this report is segmented –
1) By Type: Urinary Catheter, Ureteroscope, Shock Wave Lithotripters, Laser Therapy Systems, Other Types
2) By Application: Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis
3) By End-User: Hospitals, Ambulatory Surgical Centers, Surgical Centers, Other End-Users
Subsegments:
1) By Urinary Catheter: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters, Hydrophilic-Coated Urinary Catheters
2) By Ureteroscope: Rigid Ureteroscopes, Flexible Ureteroscopes, Semi-Rigid Ureteroscopes, Digital Ureteroscopes
3) By Shock Wave Lithotripters: Extracorporeal Shock Wave Lithotripters (ESWL), Pneumatic Shock Wave Lithotripters, Electrohydraulic Shock Wave Lithotripters, Laser-Assisted Shock Wave Lithotripters
4) By Laser Therapy Systems: Holmium Laser Therapy Systems, Thulium Laser Therapy Systems, Diode Laser Therapy Systems, Nd:YAG Laser Therapy Systems
5) By Other Types: Stents For Urinary Tract Obstruction, Percutaneous Nephrostomy Devices, Ureteral Balloon Dilation Catheters, Ureteral Access Sheaths, Urological Drainage Devices
How Are New Market Trends Shaping The Landscape Of The Urinary Tract Obstruction Treatment Devices Market?
Major companies operating in the urinary tract obstruction treatment devices market are focusing on minimally invasive, retrievable prostatic implants, providing reversible, outpatient solutions that relieve obstruction while preserving tissue and function. A retrievable prostatic stent is a small, implantable nitinol device inserted cystoscopically into the prostatic urethra to restore urine flow non-surgically and can be removed or replaced as needed. For instance, in April 2025, Rivermark Medical, a US-based medical device company, initiated the pivotal RAPID-III trial for its FloStent system, a minimally invasive nitinol prostatic implant crafted to relieve lower urinary tract symptoms from benign prostatic hyperplasia (BPH) as a primary, reversible outpatient treatment. The FloStent system aims to offer an alternative to medication and more invasive surgical procedures by gently expanding the prostatic urethra to enhance urinary flow. This study is expected to generate crucial clinical evidence on its safety, durability, and improvements in patient quality-of-life, supporting wider adoption of this implant-based approach for managing BPH.
Which Leading Companies Dominate The Urinary Tract Obstruction Treatment Devices Market Share?
Major companies operating in the urinary tract obstruction treatment devices market are Medtronic Plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast Corporation, Smiths Group plc, Bio-Rad Laboratories, Teleflex Incorporated, Paul Hartmann AG, Karl Storz SE & Co. KG, Cook Medical, Hollister Incorporated, Amsino International Inc., Richard Wolf GmbH, Braun Melsungen AG, Angiplast Pvt. Ltd., Mais India Medical Devices Pvt. Ltd., Convatec Inc., VYGON (UK) LTD., United Endoscopy, Advin Health Care, Manish Medi Innovation, MicroPort Urocare (Jiaxing) Co. Ltd., Nikotech Pvt Ltd.
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Urinary Tract Obstruction Treatment Devices Market?
North America was the largest region in the urinary tract obstruction treatment devices market in 2025. The regions covered in the urinary tract obstruction treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Urinary Tract Obstruction Treatment Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20989&type=smp
Browse Through More Reports Similar to the Global Urinary Tract Obstruction Treatment Devices Market 2026, By The Business Research Company
Uncomplicated Urinary Tract Infection Treatment Global Market Report 2026
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2026
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company